Psychopharmacology

SJR Rank #3,914H-index: 224SJR: 1.147Best quartile: Q1APC: US$4,390
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • PharmacologyQ1

Areas: Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchMemory and Neural MechanismsStress Responses and CortisolReceptor Mechanisms and SignalingNeuroendocrine regulation and behaviorNicotinic Acetylcholine Receptors StudyForensic Toxicology and Drug AnalysisSchizophrenia research and treatmentCannabis and Cannabinoid Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025080160240320

Detailed Information

ISSN

0033-3158, 1432-2072

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.38

References per Document

71.53

Coverage

1959-2026

Scope

Psychopharmacology is an international journal of research and scholarship, the aims of which are to cover the general area of elucidating the neurochemical mechanisms that affect behavior, all terms understood in the broadest sense. The scope of the Journal extends from clinical psychopharmacology (including trials), to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies (techniques covered) may range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry. The journal is particularly interested in articles that integrate these levels of analysis.

Metrics from SCImago Journal Rank 2025. View on SCImago